Diabetes Assays Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Diabetes Assays Pipeline Market Report Overview
Diabetes Assays are tests to first diagnose diabetes and assess the risk of diabetes, such as pre-diabetes, through analysis of blood. The diabetes assays pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.
| Key Territories | · The US
· Europe · India · China · South Korea |
| Key Segments | · Glycated Hemoglobin (HbA1c) Lab Assay
· Glycated Hemoglobin (HbA1c) Point of care (POC) Assay · Insulin Assay · Glycated Hemoglobin (HbA1c) Assays · C-Peptide Assay |
| Key Regulatory Paths | · 510(k)
· CE-IVD · NMPA · MDITAC · MDA |
| Leading Companies | · 1Drop Diagnostics
· Abcodia Ltd · Abionic SA · Adaptive Biotechnologies Corp · Adipomics Inc · Aditxt Inc |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Diabetes Assays Pipeline Market Segments
A few of the key segments in the diabetes assays pipeline market are Glycated Hemoglobin (HbA1c) Lab Assay, Glycated Hemoglobin (HbA1c) Point of care (POC) Assay, Insulin Assay, Glycated Hemoglobin (HbA1c) Assays, and C-Peptide Assay. As of June 2024, Glycated Hemoglobin (HbA1c) Lab Assay accounts for the highest market share.
Diabetes Assays Pipeline Market Analysis by Segments, 2024 (%)
Buy the Full Report for More Segmental Insights into the Diabetes Assays Pipeline Market
Diabetes Assays Pipeline Market Segmentation by Territories
A few of the key territories with the diabetes assays pipeline market are the US, Europe, India, China, and South Korea among others. As of June 2024, the US accounts for the highest number of pipeline products.
Diabetes Assays Pipeline Market Analysis by Territories, 2024 (%)
Buy the Full Report for More Territory Insights into the Diabetes Assays Pipeline Market
Diabetes Assays Pipeline Market Segmentation by Regulatory Paths
A few of the key regulatory paths in the diabetes assays pipeline products market are 510(k), CE-IVD, NMPA, MDA, and MDITAC. As of June 2024, 510(k) is the most followed pathway for pipeline products in the diabetes assays market.
Diabetes Assays Pipeline Market Analysis by Regulatory Paths, 2024 (%)
Buy the Full Report for More Regulatory Path Insights into the Diabetes Assays Pipeline Market
Diabetes Assays Pipeline Market – Competitive Landscape
A few of the key companies associated with the diabetes assays pipeline market are 1Drop Diagnostics, Abcodia Ltd, Abionic SA, Adaptive Biotechnologies Corp, Adipomics Inc., and Aditxt Inc., among others.
Abcodia Ltd: Abcodia Ltd (Abcodia) is a clinical-stage company that offers commercial development of novel, scientifically validated tests for the early detection of cancer. The company offers Roca Test, a blood test for early ovarian cancer detection. It validates and discovers biomarkers for early diagnosis and screening of cancer. Abcodia develops products for the detection of colorectal cancer, pancreatic cancer, and lung cancer.
Abionic SA: Abionic SA (Abionic) is a medical device company that develops, produces, and markets in vitro diagnostic devices. The company provides products such as abioSCOPE, IVD capsule, abioGUIDE, abioGUIDE application for Android, iPhone, and iPad, and accessories, among others. Its abioSCOPE in vitro tests are designed to deliver specific, semi-quantitative, and personalized information about patients’ allergen sensitization at the point of care.
Diabetes Assays Pipeline Market Analysis by Companies, 2024
Buy the Full Report for More Company Insights into the Diabetes Assays Pipeline Market
Segments Covered in the Report
Diabetes Assays Pipeline Market Segments Outlook (2024)
- Glycated Hemoglobin (HbA1c) Lab Assay
- Glycated Hemoglobin (HbA1c) Point of care (POC) Assay
- Insulin Assay
- Glycated Hemoglobin (HbA1c) Assays
- C-Peptide Assay
Diabetes Assays Pipeline Market Territories Outlook (2024)
- The US
- Europe
- India
- China
- South Korea
Diabetes Assays Pipeline Market Regulatory Paths Outlook (2024)
- 510(k)
- CE-IVD
- NMPA
- MDA
- MDITAC
Scope
This report provides:
- Extensive coverage of the diabetes assays under development.
- Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
- Reviews of major players involved in the development of diabetes assays and lists all their pipeline projects.
- Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Key clinical trial data of ongoing clinical trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
- Formulate significant competitor information, analysis, and insights to improve R&D strategies.
- Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
- Identify and understand important and diverse types of diabetes assays under development.
- Develop market-entry and market-expansion strategies.
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
- Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.
Abcodia Ltd
Abionic SA
Adaptive Biotechnologies Corp
Adipomics Inc
Aditxt Inc
Advanced Genetic Diagnostics Pty Ltd
Alfa Wassermann Inc
AmideBio, LLC
Aura Biotechnologies Pvt Ltd
Beckman Coulter Inc
Biocrates Life Sciences AG
BioDesign Institute at Arizona State University
Biogenes Technologies Sdn Bhd
Biomorph Technologies LLC
CellCarta Precision Medicine Inc
Confer Health Inc
Drexel University
Dx&Vx
Electronic BioSciences Inc.
Enable Biosciences Inc
FibroStatin SL
G Medical Innovations Holdings Ltd
GATC DB Care Corp
Gelteq Ltd
Genesis Detection Systems, Inc.
Guangzhou Wondfo Biotech Co Ltd
Helmholtz Centre for Infection Research
Hemex Health Inc
Human Cell Design SAS
Interpace Biosciences Inc
IntraMed Diagnostics, LLC
Janssen Diagnostics LLC
Johns Hopkins University
L2 Diagnostics LLC
Matter Diagnostics
MediSure Canada Inc
Mellitus LLC
MultiOmic Health Ltd
Numares AG
Peri Rx Inc
Phaim Pharma Ltd
Phase Scientific International Ltd
PortaScience Inc
Precision Diabetes LLC
Protagen AG
QSTAG Co Ltd
Queen Mary University of London
QuickCheck Health Inc
Sebia
Sera Prognostics Inc
Singulex Inc
SomaLogic Inc
SpinChip Diagnostics AS
Stanford University
Sugentech Inc
Tetz Laboratories
The Forsyth Institute
University of Canterbury
University of Colorado
University of Florida
University of Newcastle
University of Oxford
University of South Florida
University of Strathclyde
Vactech Oy
Vital Diagnostics, Inc. (Inactive)
Wave 80 Biosciences Inc
Xhale Inc
Yaathum Biotech Pvt Ltd
Yale University
Table of Contents
Table
Figures
Frequently asked questions
-
Which territory has the highest number of products in the diabetes assays pipeline market as of June 2024?
As of June 2024, the US accounts for the highest number of pipeline products in the diabetes assays market.
-
Which segment has the highest number of products in the diabetes assays pipeline market as of June 2024?
As of June 2024, Glycated Hemoglobin (HbA1c) Lab Assay accounts for the highest share of the diabetes assays pipeline market.
-
Which is the most followed regulatory pathway in the diabetes assays pipeline market as of June 2024?
As of June 2024, 510(k) is the most followed pathway for pipeline products in the diabetes assays market.
-
Which are the major companies operating in the diabetes assays pipeline market?
A few of the key companies associated with the diabetes assays pipeline market are 1Drop Diagnostics, Abcodia Ltd, Abionic SA, Adaptive Biotechnologies Corp, Adipomics Inc., and Aditxt Inc., among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Sample Report
Diabetes Assays Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:
- Assess the relevance of the report
- Evaluate the quality of the report
- Justify the cost
Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.
Related reports
View more Diabetes Assays reports
